Caribou Biosciences, Inc. (CRBU) vs Definitive Healthcare Corp. (DH)

A side-by-side comparison of Caribou Biosciences, Inc. and Definitive Healthcare Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CRBU vs DH

growth of $100 · dividends reinvested · last 5y
CRBU -95.9% (-47.2%/yr)DH -97.7% (-53.1%/yr)CRBU compounded faster over this window
050100Start $10020222023202420252026$4$2
CRBU DH

CRBU vs DH: by the numbers

  • •CRBU is the larger company ($117M vs $105M market cap).
  • •Both run net losses; DH's is the smaller (-72.28% vs -1030.42% net margin).
  • •DH grew revenue faster over the past five years (10.62% vs -2.03% CAGR).

Metrics side by side

Valuation

MetricCRBUDH
Forward P/EN/A5.12
P/S ratio11.610.45
P/B ratio1.190.73
EV / EBITDAN/A0.49
FCF yieldN/A27.16%

Profitability

MetricCRBUDH
Gross margin67.34%71.67%
Operating margin-1220.49%-8.52%
Net margin-1030.42%-72.28%
ROE-105.40%-116.28%
ROIC-87.72%41.64%

Growth (annualized)

MetricCRBUDH
Revenue CAGR (5Y)-2.03%10.62%
FCF CAGR (5Y)N/A2.14%
Total return CAGR (5Y)-44.43%-52.54%

Frequently asked

Which has grown faster, CRBU or DH?
Over the past five years, DH grew revenue faster — CRBU at a -2.03% CAGR versus DH at 10.62%.
How have CRBU and DH total returns compared?
Over the past 5 years, CRBU delivered -44.43% and DH delivered -52.54% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.